| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -14,566 | - |
| Depreciation | 261 | 178 |
| Accumulated amortization | 0 | 0 |
| Goodwill impairment | 2,783 | - |
| Share-based payment arrangement, noncash expense | 576 | 402 |
| Information about earnout remeasured | -608 | -608 |
| Interest income | 0 | 0 |
| Exchange rate fluctuations | 103 | 70 |
| Trade receivables, net | 122 | -140 |
| Prepaid expenses, operating lease right-of-use assets and other assets | -119 | 33 |
| Inventories | 465 | 938 |
| Increase (decrease) in accounts payable, trade | -300 | 567 |
| Increase (decrease) in employee related liabilities | -80 | -158 |
| Increase (decrease) in deferred liabilities | -199 | -229 |
| Increase (decrease) in other operating liabilities | -567 | -67 |
| Negative cash flow from operations | -13,271 | -9,429 |
| Purchase of property and equipment | 5 | 5 |
| Net cash provided by (used in) investing activities | -5 | -5 |
| Issuance of ordinary shares in a 'registered direct' offering, net of issuance expenses in the amount | 4,442 | 4,442 |
| Issuance of ordinary shares under at the market offering net of issuance costs | 1,774 | 1,128 |
| Issuance of ordinary shares in a in a public offering net of issuance expenses in the amount | 2,209 | 2,209 |
| Net cash provided by (used in) financing activities | 8,425 | 7,779 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 103 | 70 |
| Cash, cash equivalents, restricted cash, and restricted cash equivalents, period increase (decrease), including exchange rate effect | -4,748 | -1,585 |
| Cash and cash equivalents at beginning of period | 7,108 | - |
| Cash and cash equivalents at end of period | 2,360 | - |
Lifeward Ltd. (LFWD)
Lifeward Ltd. (LFWD)